|04-15-2019 04:10 PM CET - Advertising, Media Consulting, Marketing Research||
Influenza Diagnostics Market Size, Share | Industry Report 2026
Press release from: Ameri Research Inc.
The global Influenza Diagnostics Market was valued at $xx Billion in 2018 and is forecast to grow at a modest xx % CAGR between2018 and 2025, culminating in 2026 global sales of $xx Billion.
Influenza Diagnostics is a test used to detect negative-sense standard RNA virus under the Orthomyxoviridae family known as “Flu”. It is a high spreadable viral disease of the respiratory passages of mammals and birds including us. Also, it is the most acquainted virus in the present world. There are three types of influenza virus known as Influenza A, B, C. It can be transferred from patient to another person easily, it also can communicate by climate region. If the Children, elderly population, and pregnant women will face this type of viral disease, then it will be a high risk for them. It can be avoided by antiviral drugs and vaccines treatment with effective way. Many laboratories having advance technology of medical equipment to identify the Influenza virus. So, rising of geriatric population and their chronic diseases such as heart, blood disorders, and diabetes and owing to advance technology influenza diagnostics test playing a major role to drive the market.
We have observed that the significant growth of Influenza Diagnostics followed by the RIDT Testhas the largest share of the global market which expected to be the fastest growing device over the forecast period. This test having simple to perform and provide the result as little as 15 minutes.
Click the link below to view the report description:
Key findings from the study: -
• We have segmented the Global Influenza Diagnostics based on Test Types as RIDT, RT-PCR, Cell Culture.
• We have segmented the Global Influenza Diagnostics based on End-Use as Hospitals, Laboratories, POCT.
• The key market participants include Roche Diagnostics, Becton, Meridian Bioscience, Inc., Dickinson and Company, Thermo Fisher Scientific, Alere, and Quidel Corporation.
Ameri Research has segmented the Influenza Diagnostics Market by material categories, product type, end-use and region:
Global Influenza Diagnostics Market by Test Types (Revenue, Million, 2018 – 2026)
• Cell Culture
Global Influenza Diagnostics Market by End-Use (Revenue, Million, 2018 – 2026)
Global Influenza Diagnostics Market Regional Outlook (Revenue, USD Million, 2018-2026)
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
o South Africa
o Saudi Arabia
Browse Full Report @ www.ameriresearch.com/product/influenza-diagnostics-market/
Ameri Research Inc. (www.ameriresearch.com) is a U.S. based market research and consulting company, registered in the State of Florida and headquartered in Tampa Bay Area. At Ameri Research we are passionately curious about people, markets, brands and society. Our ability to gauge market movements, deep expertise in data science, strong domain expertise and years of collective global experiences helps us to bring unmatched quality in deliverables to our clients. With carefully planned systems and processes in place, we cater to the requirements of our clients in a timely and cost-efficient manner, bringing increased predictability to their business. Each year we are publishing more than 100 syndicated reports in healthcare, chemicals, materials, food & beverages, defense & aerospace, media & entertainment, sports & fitness, and energy. We offer our clients a unique depth of knowledge and expertise around-
Market Entry Strategy
Developing a culture of collaboration and curiosity, we attract the highest caliber of likeminded people having ability to influence and shape the future.
Follow us on LinkedIn for our latest upcoming reports www.linkedin.com/company/ameri-research-inc./
Follow us on Facebook for our latest upcoming reports www.facebook.com/AmeriResearchInc/
Follow us on Twitter for our latest upcoming reports www.twitter.com/AmeriResearch
Ameri Research Inc.
6816 Muncaster Ct,
Tampa, FL 33625
This release was published on openPR.
News-ID: 1703697 • Views: 510More releases